In, Gino K. https://orcid.org/0000-0002-7060-5123
Vaidya, Poorva
Filkins, Alexandra
Hermel, David J.
King, Kevin G.
Ragab, Omar
Tseng, William W.
Swanson, Mark
Kokot, Niels
Lang, Julie E.
Menendez, Lawrence
DeClerck, Brittney
Kim, Gene
Hu, Jenny C.
Terando, Alicia
Jadvar, Hossein
Ricker, Charité
Miller, Kimberly A.
Peng, David H.
Wysong, Ashley
Article History
Received: 26 August 2020
Accepted: 6 November 2020
First Online: 18 November 2020
Compliance with ethical standards
:
: Gino K. In: advisory boards/consulting for Sanofi, BMS, Novartis, Array, and Castle Biosciences; speaker for Merck; clinical trials/research support from Genentech, Idera, and Regeneron. Julie E. Lang: speaker for Genomic Health; research support from ANGLE Parsortix. Jenny C. HU: advisory board for Regeneron. Ashley Wysong: research support from Castle Biosciences. All the other authors: no conflicts.
: This study was reviewed and approved by the institutional review board at the University of Southern California. The study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.
: Informed consent was obtained from all the individual participants included in the study.
: Informed consent was obtained from all the individual participants included in the study.
: The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request. All data and materials support the published claims and comply with field standards. This work has been partially presented in abstract form at the 2018 ASCO Annual Meeting. Otherwise, all the other content has not been published elsewhere, nor is under consideration for publication anywhere else.